Hyperglycemia and Phosphatidylinositol 3‐Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management
2010 ◽
Vol 184
(12)
◽
pp. 6600-6611
◽
2015 ◽
Vol 29
(5)
◽
pp. 731-738
◽
2020 ◽
Vol 12
(6)
◽
pp. 500-513
◽
2018 ◽
Vol 57
(10)
◽
pp. S229
2018 ◽
Vol 120
(3)
◽
pp. 3833-3844
◽
2013 ◽
Vol 41
(10)
◽
pp. 1769-1777
◽
2003 ◽
Vol 278
(31)
◽
pp. 28644-28650
◽